None listed
Conditions
Interventions
Intervention1: Rosewater: Dab it directly on the face and forearm with a cotton pad until it get absorbed.
duration 1 day
Control Intervention1: Not Applicable: Not Applicable
Sponsors
Dabur India Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1) Age: 18 to 55 years (both inclusive) old at the time of consent. 2) Sex: Healthy human non-pregnant/non-lactating females. 3) Frequent regular users of rosewater. 4) Females of childbearing potential must have a self-reported negative urine pregnancy test. 5) Subjects are generally in good general health as determined from recent medical history. 6) Subjects forearm must be free of cuts, tattoos, scratches, abrasions, scars, uneven skin tone, sunburn, excessive tan, excessive hair or open wounds on or near the test sites. 7) The subject is willing and able to follow the study directions, participate in the study, returning for all specified visits. 8) The subject must be able to understand and provide written informed consent to participate in the study.
Exclusion criteria
Exclusion criteria: 1) Subject with known allergy or sensitization to product ingredients rose oil, aloe vera. 2) The subject has clinically significant skin disease, which may contraindicate participation, including psoriasis, eczema, Skin cancer or other skin pathology. 3) Subject participation in the study involving the only one application of a personal care product such as lotion or cleansing product to the test area with no invasive procedure within the four weeks prior to enrolment. 4) Medication which may affect skin response and/or past medical history. 5) Topical drugs used at the application site. 6) An individual who has a medical condition or is taking or has taken a medication which, in the Investigator’s judgment, makes the subject ineligible or places the subject at undue risk. 7) Participation in other clinical studies simultaneously.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the effectiveness of the test product in terms of change in 1. Skin hydration/ moisturization 2. Skin pH 3. Deep Skin PenetrationTimepoint: From baseline to T0, T15min, and T8 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the safety of the test product in terms of change in Visual evaluationTimepoint: From baseline to T0, T2, T4, T6, T8 hours;To evaluate the product effectiveness in terms of subject response indexTimepoint: From baseline to T0, T2, T4, T6, T8 hours | — |
Countries
India
Contacts
Public ContactMaheshvari Patel
NovoBliss Research Private Limited
Outcome results
None listed